Solaris Pharma
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1031g Route 202 South Ste 200, Bridgewat...Phone Number
(908) 800-0300Website
www.solaris-pharma.comRevenue
$7.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About Solaris Pharma
Solaris Pharma Corporation is a leading specialty pharmaceutical company focused on the identification, development, and marketing of high-quality, complex generic and specialty pharmaceutical products. The company boasts an experienced R&D and management team dedicated to right-first-time development while adhering to the highest quality standards. With a strong financial position and an employee-centric approach, Solaris Pharma aims to be a leader in the niche pharmaceutical market. Their product pipeline includes various challenging dosage forms such as sterile, dermatological, and tablet products.Explore more
Solaris Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Solaris Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Solaris Pharma had a recent Job posting/layoffs
Check if Solaris Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Solaris Pharma
Check out if Solaris Pharma is spiking on competitors!
Earning: See what the market has to say on Solaris Pharma recently announced quarterly report
Solaris Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Solaris Pharma launches new products
Funding: Get notified immidiatlly once Solaris Pharma has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Solaris Pharma
Find more new buyers
Compare Similar Companies to Solaris Pharma
Compare insights from companies similar to Solaris Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$9.1M
11-50
Private
$6.8M
2015
Company Profile Activity
Activity Insights
Solaris Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Solaris Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Solaris Pharma.
Solaris Pharma financials insights
Gather financial insights about Solaris Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
2021
Debt
$801K
Solaris Pharma Tech Stack
A closer look at the technologies used by Solaris Pharma
Solaris Pharma News & Media
Solaris Pharma Receives Approval for First Generic Version of Clindagel® (clindamycin phosphate EQ 1%)
BRIDGEWATER, N.J., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Solaris Pharma Corporation (“Solaris” or the “Company”) announced today that the Company has received an abbreviated new drug application (“ANDA”) approval from the U.S. Food and Drug Administration (“FDA” or “Agency”) for the first generic version of Clindagel® (clindamycin phosphate EQ 1%). This product will be manufactured in the United States by Cosette, Solaris’ manufacturing partner. The product will be launched immediately.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Solaris Pharma
Sign Up For FreeTo access detailed company insights
Solaris Pharma Corporation is a leading specialty pharmaceutical company focused on the identification, development, and marketing of high-quality, complex generic and specialty pharmaceutical products. The company boasts an experienced R&D and management team dedicated to right-first-time development while adhering to the highest quality standards... Read More
